Literature DB >> 17763181

Adiponectin, obesity and atherosclerosis.

C J Behre1.   

Abstract

The circulating protein adiponectin has been the subject of immense interest ever since it was first discovered in the mid-1990s. The protein is uniquely produced and secreted by mature adipocytes and is believed to have important anti-inflammatory and anti-diabetic effects; low levels have been shown to be predictive of future type 2 diabetes and cardiovascular disease. This review discusses adiponectin in relation to obesity, inflammation, insulin resistance and atherosclerosis.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17763181     DOI： 10.1080/00365510601158717

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN： 0036-5513            Impact factor:   1.713


  8 in total

1.  Adiponectin is associated with risk of the metabolic syndrome and insulin resistance in women.

Authors:  George A King; Sarah E Deemer; Dixie L Thompson
Journal:  Acta Diabetol       Date:  2010-05-08       Impact factor: 4.280

Review 2.  [Adipokine update - new molecules, new functions].

Authors:  Carmen Gelsinger; Alexander Tschoner; Susanne Kaser; Christoph F Ebenbichler
Journal:  Wien Med Wochenschr       Date:  2010-08

3.  Lower adiponectin is associated with subclinical cardiovascular disease among HIV-infected men.

Authors:  Kerunne S Ketlogetswe; Wendy S Post; Xiuhong Li; Frank J Palella; Lisa P Jacobson; Joseph B Margolick; Lawrence A Kingsley; Mallory D Witt; Adrian S Dobs; Matthew J Budoff; Todd T Brown
Journal:  AIDS       Date:  2014-03-27       Impact factor: 4.177

Review 4.  Obesity and osteoarthritis: disease genesis and nonpharmacologic weight management.

Authors:  Stephen P Messier
Journal:  Rheum Dis Clin North Am       Date:  2008-08       Impact factor: 2.670

5.  Adipokines, insulin resistance, and coronary artery calcification.

Authors:  Atif Qasim; Nehal N Mehta; Mahlet G Tadesse; Megan L Wolfe; Thomas Rhodes; Cynthia Girman; Muredach P Reilly
Journal:  J Am Coll Cardiol       Date:  2008-07-15       Impact factor: 24.094

6.  Additional effect of diabetes mellitus type 2 on the risk of coronary artery disease: role of serum adiponectin.

Authors:  Ghorban Mohammadzadeh; Mohammad-Ali Ghaffari
Journal:  Iran Red Crescent Med J       Date:  2014-01-05       Impact factor: 0.611

7.  Serum and aqueous humor adiponectin levels correlate with diabetic retinopathy development and progression.

Authors:  Hyun Seung Yang; Young Je Choi; Hee Yong Han; Hak Su Kim; So Hyun Park; Kyung Sub Lee; Sang Hwa Lim; Doo Jin Heo; Sangkyung Choi
Journal:  PLoS One       Date:  2021-11-15       Impact factor: 3.240

8.  Increased high molecular weight adiponectin and lean mass during tocilizumab treatment in patients with rheumatoid arthritis: a 12-month multicentre study.

Authors:  Eric Toussirot; Hubert Marotte; Denis Mulleman; Grégoire Cormier; Fabienne Coury; Philippe Gaudin; Emmanuelle Dernis; Christine Bonnet; Richard Damade; Jean-Luc Grauer; Tassadit Ait Abdesselam; Caroline Guillibert-Karras; Frédéric Lioté; Pascal Hilliquin; Antoinette Sacchi; Daniel Wendling; Benoît Le Goff; Marc Puyraveau; Gilles Dumoulin
Journal:  Arthritis Res Ther       Date:  2020-09-29       Impact factor: 5.156
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.